Interview 13 Mar 2017
Meet the Omics Entrepreneur who also Co-Founded EMBL
…you comment on how you find it in Germany? Compared to the United States, Germany has a much shorter tradition in biotech. It was first at the end of the…
Search Results for: united kingdom
More News! 8 Feb 2017
The FDA lays down Laws of Interchangeability: New Era for Biosimilars?
…and future drugs as more products can be substituted for a reference by a pharmacist without the approval of a health care provider. The United States did have an “interchangeable”…
News and Trends 27 Jun 2022
Saudi Arabia to inject $3B into vaccines and medicines industry
…vital medicines committee, Bandar bin Ibrahim Alkhorayef, has announced the launch of several investment opportunities in the vaccines and vital medicines industry, valued at $3.4 billion, to achieve the Kingdom’s…
Country A – Z Index
…Latin America M Malaysia N Netherlands New Zealand Norway P Poland Portugal R Russia S Saudi Arabia Scotland Singapore South Korea Spain Sweden Switzerland T Taiwan U United Kingdom USA…
ADVERTISEMENT
News and Trends 3 Apr 2017
New Results Show GM Mosquitoes Keep Dengue and Zika at Bay in Brazil
In its second year, Oxitec has reduced the mosquito population in a Brazilian neighborhood by 81%, demonstrating the long-term potential of GM insects. Oxitec is a spin-out from the University…
News and Trends 8 Sep 2022
OncoBone signs deals with three partners to work on bone metastases
OncoBone Ventures has signed cooperation framework agreements with three partners. The company is a U.K. start up biotech looking to develop novel therapies for cancer patients with currently incurable bone…
News and Trends 8 May 2017
Immunocore Boosts its Collaboration with GSK with new Lead Compound
Immunocore has singled out a new lead candidate in its immuno-oncology discovery program with GSK, triggering an undisclosed milestone payment to Immunocore. Based in Oxford, Immunocore is one of the…
News and Trends 1 Sep 2017
Allergan Takes to the Clinic a New Alzheimer’s Drug from a €3Bn Deal
Allergan’s partner Heptares Therapeutics has dosed the first patient with a GPCR drug to treat major symptoms of Alzheimer’s disease. A year ago, Allergan signed a massive deal of up…
News and Trends 11 Oct 2018
Rechargeable Dentures Could Prevent Mouth Infections
As well as helping you chew your hamburger, dentures could one day fight oral fungal infections, suggest researchers from Manchester Metropolitan University, UK. The population is getting older. In fact,…
News and Trends 13 Oct 2016
Adaptimmune Revises TCR Protocol following Phase I/IIa Failure
Shares of Adaptimmune slid 12% yesterday morning after the company updated its TCR therapy to include fludarabine, which was linked to deaths in Juno’s CAR-T trials. Despite optimism that T-cells…
News and Trends 16 Aug 2022
Pneumagen embarks on phase 2 proof of concept influenza study
Biotech company Pneumagen says the first person has been dosed in its phase 2 controlled human infection challenge study. Its product, Neumifil, is an intranasal, broad-spectrum antiviral treatment to prevent…
News and Trends 14 Oct 2022
Beyond Biotech podcast 18: BiotechX, Cultivated Biosciences, EPFL, Faron Pharmaceuticals
This week, we have four interviews. Our guests are: Juho Jalkanen, COO of Faron Pharmaceuticals; Ardemis Boghossian and Melania Reggente from the EPFL School of Basic Sciences in Switzerland; Tomas…
